Yubo Xiao

861 citations
21 papers · 587 indexed · h-index 13
Topics
Berberine and alkaloids research (7 papers)MicroRNA in disease regulation (2 papers)Antimicrobial Resistance in Staphylococcus (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Yubo Xiao

19 papers receiving 587 citations

Peers

Yubo Xiao
Comparison fields: 5 of 94
  • Molecular Biology 302
  • Pharmacology 187
  • Infectious Diseases 108
  • Pharmacology 95
  • Epidemiology 89
Replace Jung‐woo Chae with:
Jung‐woo Chae South Korea
Shuxian Chen China
Madhu Cholenahalli Lingaraju India
Edmund Jon Deoon Lee Singapore
Toshiharu Hirose Japan
Ren Xiang Tan China
Rongxin Qin China
Zhonghong Wei China
Shin Saitoh Japan
Li Liao China
Yubo Xiao relative to Jung‐woo Chae South Korea Jung‐woo Chae's profile →
Citations per field
00.5×1.5×1.9×
Jung‐woo Chae · 1×
Citations per year

Countries citing papers authored by Yubo Xiao

Since Specialization
Citations

This map shows the geographic impact of Yubo Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yubo Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yubo Xiao more than expected).

Fields of papers citing papers by Yubo Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yubo Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yubo Xiao. The network helps show where Yubo Xiao may publish in the future.

Co-authorship network of co-authors of Yubo Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Yubo Xiao. A scholar is included among the top collaborators of Yubo Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yubo Xiao. Yubo Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 3
5 44
6 12
7 15
8 55
9 39
10 27
11
Anti-hypercholesterolemic Effect of Berbamine Isolated from Rhizoma Coptidis in Hypercholesterolemic Zebrafish Induced by High-Cholesterol Diet.
10
12 22
13 21
14 59
15 60
16 37
17 118
18 38
19 15
20 9

About Yubo Xiao

Yubo Xiao is a scholar working on Pharmacology, Pharmacology and Reproductive Medicine, having authored 21 papers that have together received 587 indexed citations. Recurring topics across this work include Berberine and alkaloids research (7 papers), MicroRNA in disease regulation (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Pharmacology (187 citations), Pharmacology (95 citations) and Drug Discovery (1 citation). Yubo Xiao has collaborated with scholars based in China and United States. Frequent co-authors include Xuegang Li, Xiaoli Ye, Hang Ma, Kai He, Yinran Hu, Zongyao Zou, Min Feng, Changcheng Shi, Nengming Lin and Yong Yang. Their work appears in journals such as Scientific Reports, Life Sciences and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026